Search results for "030211 gastroenterology & hepatology"

showing 10 items of 1275 documents

Review: Epidemiology of Helicobacter pylori infection

2019

This review summarizes recent publications on the epidemiology of Helicobacter pylori. Two major systemic analyses, from Malaysia and Ethiopia, were published. The Brazilian Consensus Conference has stated that H pylori infection is an infectious disease with an indication for antimicrobial therapy. A continuous decrease in H pylori prevalence was reported from many regions worldwide, including Korea, China, Iran, and Austria. A cross-sectional H pylori prevalence study conducted in the United Arab Emirates found 41% prevalence in a group of healthy children and adults. Several studies from Asia addressed H pylori prevalence in adults undergoing regular checkup. The largest of such studies,…

medicine.medical_specialtyPrevalenceDiseaseGlobal HealthHelicobacter Infections03 medical and health sciences0302 clinical medicineRisk FactorsEnvironmental healthEpidemiologyPrevalencemedicineHumansSeroprevalenceStomach cancerHelicobacter pyloribiologybusiness.industryGastroenterologyWaterborne diseasesGeneral MedicineHelicobacter pyloribiology.organism_classificationmedicine.diseaseInfectious DiseasesInfectious disease (medical specialty)030220 oncology & carcinogenesis030211 gastroenterology & hepatologybusinessHelicobacter
researchProduct

Rockall Score Larger Than 7 as a Reliable Criterion for the Selection of Indications for Preventive Transarterial Embolization in a Subgroup of High-…

2017

Background Transarterial embolization (TAE) is an alternative procedure to repeat endoscopy or surgical intervention in the case of re-bleeding after primary endoscopic treatment. The aim of the study was to assess the Rockall score as a criterion for TAE in the case of re-bleeding after endoscopic treatment of non-variceal upper gastrointestinal bleeding (NVUGIB). Methods Out of the 673 patients who underwent emergent endoscopic hemostasis due to NVUGIB, 111 had a high risk of re-bleeding having a Forrest I-IIb ulcer and the Rockall score ≥ 5. From 111 patients, 37 accepted preventive TAE (PE+ group). The control group consisted of 74 patients who underwent standard treatment (PE- group). …

medicine.medical_specialtyPreventive embolizationmedicine.diagnostic_testbusiness.industryStandard treatmentRockall scoremedicine.diseaseEndoscopySurgery03 medical and health sciencesEndoscopic hemostasis0302 clinical medicineTransarterial embolizationmedicineNon-variceal upper gastrointestinal bleeding030211 gastroenterology & hepatologyOriginal Article030212 general & internal medicineUpper gastrointestinal bleedingbusinessRockall scoreRisk assessmentEndoscopic treatmentRisk assessmentGastroenterology Research
researchProduct

Contrast-Enhanced Ultrasound in Focal Liver Lesions: Where Do We Stand?

2016

Contrast-enhanced ultrasound (CEUS) represents a significant breakthrough in sonography, and it is being increasingly used for the evaluation of focal liver lesions (FLLs). Currently, CEUS is included as a part of the suggested diagnostic workup of FLLs, resulting in a better patient management and delivering cost-effective therapy. After a brief technical note, contrast-enhancement patterns of different types of benign and malignant FLLs, along with hepatic pseudolesions, are described and discussed based on our experience and literature data. At the same time, the most recent concepts and the use of CEUS in different clinical settings are presented.

medicine.medical_specialtyRadiology Nuclear Medicine and ImagingMEDLINEContrast MediaClinical settingsSensitivity and Specificity030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineText miningmedicineHumansUltrasonographybusiness.industryLiver DiseasesLiver DiseaseUltrasoundTechnical noteImage EnhancementPatient management030211 gastroenterology & hepatologyRadiologybusinessSettore MED/36 - Diagnostica Per Immagini E RadioterapiaContrast-enhanced ultrasoundHuman
researchProduct

First-in-man permanent laparoscopic fixation free obliteration of inguinal hernia defect with the 3D dynamic responsive implant ProFlor-E®. Case repo…

2020

Abstract Introduction In the case of inguinal hernia recurrence after primary anterior repair, international guidelines strongly suggest a posterior laparoscopic approach. The 3D dynamic-responsive prosthesis for inguinal hernia repair ProFlor-E® has recently been introduced to the market. The present report describes the results of the first-in-man laparoscopic inguinal hernia repair carried out with ProFlor-E®. Presentation of case A 71-year-old male Caucasian presented with recurrent inguinal hernia after primary anterior repair. A fixation free TAPP procedure with ProFlor-E® was planned. Implant delivery and placement to obliterate the defect was quick and safe. Postoperatively, startin…

medicine.medical_specialtyRegenerative scaffoldmedicine.medical_treatmentCase ReportProFlor prosthesisProsthesisMesh fixation03 medical and health sciencesFixation (surgical)0302 clinical medicineLaparoscopicInguinal hernia repairMedicineHerniaDynamic responsivitybusiness.industryChronic painInvaginationmedicine.diseaseSurgeryInguinal herniaFixation free hernia repair030220 oncology & carcinogenesis030211 gastroenterology & hepatologySurgeryImplantbusinessInternational Journal of Surgery Case Reports
researchProduct

Repeated resection for recurrent intrahepatic cholangiocarcinoma: A retrospective German multicentre study.

2020

Background Tumour recurrence is common after resection of intrahepatic cholangiocarcinoma (ICC). Repeated resection is a potential curative treatment, but outcomes are not well-defined thus far. The aim of this retrospective multicentre cohort study was to show the feasibility and survival of repeated resection of ICC recurrence. Methods Data were collected from 18 German hepato-pancreatico-biliary centres for patients who underwent repeated exploration of recurrent ICC between January 2008 and December 2017. Primary end points were overall (OS) and recurrence-free survival from the day of primary and repeated resection. Results Of 156 patients who underwent repeated exploration for recurre…

medicine.medical_specialtyResectionCholangiocarcinomaCohort Studies03 medical and health sciences0302 clinical medicineMedicineHepatectomyHumansIntrahepatic CholangiocarcinomaRetrospective StudiesHepatologybusiness.industryPrimary resectionRecurrent Intrahepatic Cholangiocarcinoma3. Good healthTumor recurrenceSurgeryTreatment OutcomeBile Duct NeoplasmsMedian timeCurative treatment030220 oncology & carcinogenesis030211 gastroenterology & hepatologyNeoplasm Recurrence LocalbusinessCohort studyLiver international : official journal of the International Association for the Study of the LiverReferences
researchProduct

Right posterior diaphragmatic hernia (Bochdalek) with liver involvement and alteration of hepatic outflow in adult: a case report

2016

Introduction Posterior right diaphragmatic hernia is rare in newborn patients but when present, is accompanied by high mortality. Pulmonary hypoplasia seems to be the main cause of death but the presence of liver involvement remains one of the reasons for poor prognosis even when intrauterine surgery is performed. Case Description In this article, we will present a rare case that was diagnosed by chance in a 65-year old adult presenting with an adenocarcinoma of the rectosigmoid junction and a right Bochdalek hernia with liver herniation and modification of the hepatic vein outflow with a natural right to left shunt. Discussion Diaphragmatic repair was performed on the patient with a mash a…

medicine.medical_specialtyRight-to-left shuntDiaphragmatic breathingHepatic veinBochdalek03 medical and health sciencesPulmonary hypoplasia0302 clinical medicinemedicine.arterymedicineDiaphragmatic herniaRight diaphragmatic herniaVeinCause of deathMultidisciplinaryCase Studybusiness.industryLiver herniationmedicine.diseaseSurgeryBochdalek herniamedicine.anatomical_structure030220 oncology & carcinogenesisAdenocarcinoma030211 gastroenterology & hepatologybusinessSpringerPlus
researchProduct

Rate of Post-Operative Pancreatic Fistula after Robotic-Assisted Pancreaticoduodenectomy with Pancreato-Jejunostomy versus Pancreato-Gastrostomy: A R…

2021

Background: Different techniques of pancreatic anastomosis have been described, with inconclusive results in terms of pancreatic fistula reduction. Studies comparing robotic pancreaticogastrostomy (PG) and pancreaticojejunostomy (PJ) are scarcely reported. Methods: The present study analyzes the outcomes of two case-matched groups of patients who underwent PG (n = 20) or PJ (n = 40) after pancreaticoduodenectomy. The primary aim was to compare the rate of post-operative pancreatic fistula. Results: Operative time (375 vs. 315 min, p = 0.34), estimated blood loss (270 vs. 295 mL, p = 0.44), and rate of clinically relevant post-operative pancreatic fistula (12.5% vs. 10%, p = 0.82) were simil…

medicine.medical_specialtyRobotic assistedmedicine.medical_treatmentAnastomosisArticlerobotic pancreatic surgery03 medical and health sciences0302 clinical medicinepancreatic fistulaBlood lossMedicinePost operativebusiness.industryRGeneral MedicinePancreaticoduodenectomymedicine.diseaseGastrostomySurgeryPancreatic fistulapancreato-gastrostomy030220 oncology & carcinogenesisJejunostomyMedicine030211 gastroenterology & hepatologybusinessJournal of Clinical Medicine
researchProduct

Tangential Venous Resections during Robotic-Assisted Pancreaticoduodenectomy: the Results of a Case Series (with Video)

2020

Introduction: Despite the potential advantages in terms of microdissection and microsuturing capabilites, the robotic approach for borderline resectable pancreatic cancer is scarcely reported. Methods: We report our technique for a robotic-assisted pancreaticoduodenectomy with tangential Portal/ Superior Mesenteric Vein resection/reconstruction (RPD PV/SMV).We also compared the surgical outcomes of eight consecutive patients undergoing RPD PV/SMV with that of sixty patients who underwent robotic-assisted pancreaticoduodenectomy (RPD) in the same period of time. Results: A total of eight consecutive patients underwent RPD PV/SMV. We observed an increased estimated blood loss (550 vs 280 mL, …

medicine.medical_specialtyRobotic assistedmedicine.medical_treatmentPancreaticoduodenectomyResection03 medical and health sciencesMesenteric VeinsPancreatectomy0302 clinical medicineRobotic Surgical ProceduresBlood lossBorderline resectablemedicineHumansSuperior mesenteric veinRetrospective StudiesPortal Veinbusiness.industryGastroenterologyPancreaticoduodenectomyVascular resectionSurgeryPancreatic NeoplasmsVideo techniqueTreatment Outcome030220 oncology & carcinogenesisOperative time030211 gastroenterology & hepatologySurgeryRobotic-assisted pancreaticoduodenectomybusinessHospital stay
researchProduct

Perception of improved state of health and subjective quality of life in Crohn's disease patients treated with Infliximab.

2009

International audience; UNLABELLED: BACKGROUND AND AIMS AND METHOD: Although Infliximab is a very potent therapy of refractory Crohn's disease, its administration requires iterative infusions in hospital and there are concerns regarding its long-term safety. The aim of this study was to assess in a sample of 51 patients suffering from CD the impact of type of treatment (intravenous Infliximab versus conventional therapy without Infliximab) on the evaluation of the state of health (CGI) and the quality of life (MOS-SF36). Secondary variables were also assessed: the impact of depression (MADRS), the impact of activity of the disease (Harvey-Bradshaw Index). RESULTS: Overall, the assessments m…

medicine.medical_specialtySF-36State of health[SHS.PSY]Humanities and Social Sciences/PsychologyDisease03 medical and health sciences[ SHS.PSY ] Humanities and Social Sciences/Psychology0302 clinical medicineQuality of lifeRefractoryInternal medicinemedicine030212 general & internal medicineDepression (differential diagnoses)ComputingMilieux_MISCELLANEOUSCrohn's diseasebusiness.industry[CHIM.ORGA]Chemical Sciences/Organic chemistryGastroenterologyGeneral Medicinemedicine.diseaseInfliximab3. Good healthPhysical therapy030211 gastroenterology & hepatologybusinessmedicine.drug
researchProduct

Optimizing diagnostic approach to drug-induced liver injury

2018

Drug-induced liver injury (DILI) is often a trial even to expert clinicians, because sometimes diagnosis is not easy to be made. Guidelines of the American College of Gastroenterology (ACG) yielded in 2014, help to better understand the problem. The diagnosis of DILI is made through a detailed evaluation of clinical, serological, radiological and histological aspects. Biochemical data include liver function tests that allow to assess the pattern of damage, such as hepatocellular, cholestatic and mixed liver injury; serological data include testing for major and possibly minor hepatotropic viruses, non-organ specific autoantibodies. Clinical scenario might include jaundice, nausea, vomiting …

medicine.medical_specialtySettore MED/09 - Medicina InternaDrug-induced liver injurydiagnosisclinical approach.lcsh:MedicineClinical approach03 medical and health sciencesDrug withdrawalLiver disease0302 clinical medicinemedicineEosinophiliaLiver injurymedicine.diagnostic_testbusiness.industryMedicine (all)lcsh:RGeneral MedicineJaundicemedicine.disease030220 oncology & carcinogenesisLiver biopsy030211 gastroenterology & hepatologyRadiologymedicine.symptomTransient elastographybusinessLiver function testsDiagnosiItalian Journal of Medicine
researchProduct